Neuromuscular monitoring at the orbicularis oculi may overestimate the blockade in myasthenic patients

Anesthesiology

Volumn 93, Issue 5, 2000, Pages 1194-1197

  Itoh, H ^a   Shibata, K ^a   Yoshida, M ^a   Yamamoto, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acceleration; Myasthenia gravis; Nondepolarizing neuromuscular blocker; Osserman classification

Indexed keywords

FENTANYL; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; SEVOFLURANE; THIOPENTAL; VECURONIUM;

ADDUCTOR POLLICIS MUSCLE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTUBATION; FACIAL NERVE; HAND MUSCLE; HUMAN; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING; ORBICULARIS OCULI MUSCLE; PATIENT MONITORING; PRIORITY JOURNAL; ULNAR NERVE;

EID: 0033756482     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200011000-00010     Document Type: Article

References (16)

1. Muscle disease, Anesthesia and Uncommon Disease, 3rd edition
2. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans
3. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles
4. Blood flow and mivacurium-induced neuromuscular block at the orbicularis oculi and adductor pollicis muscles
5. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients
6. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
7. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis
8. The action of d-tubocurarine and decamethonium on the respiratory and other muscles in the cat
9. A differentiation between red and white muscle in the cat based on responses to neuromuscular blocking agents
10. Muscle fibre diameter and sensitivity to neuromuscular blocking drugs
11. Duration of succinylcholine and vecuronium blockade but not potency correlates with the ratio of endplate size to fibre size in seven muscles in the goat
12. Up-and-down regulation of skeletal muscle acetylcholine receptors
13. Vecuronium for muscle relaxation in patients with myasthenia gravis
14. Sensitivity to vecuronium in myasthenia gravis: A dose-response study
15. Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis
16. Neuromuscular response to succinylcholine-vecuronium sequence in three myasthenic patients undergoing thymectomy